Evaluation of a blood-based geroscience biomarker index in a randomized trial of caloric restriction and exercise in older adults with heart failure with preserved ejection fraction

被引:0
作者
Jamie N. Justice
Nicholas M. Pajewski
Mark A. Espeland
Peter Brubaker
Denise K. Houston
Santica Marcovina
Barbara J. Nicklas
Stephen B. Kritchevsky
Dalane W. Kitzman
机构
[1] Wake Forest School of Medicine,Department of Internal Medicine, Section On Gerontology and Geriatric Medicine
[2] Wake Forest School of Medicine,Department of Biostatistics and Data Science
[3] Forest University in Winston-Salem,Department of Health and Exercise Science at Wake
[4] Medpace Reference Laboratories,undefined
[5] Department of Internal Medicine,undefined
[6] Section On Cardiology,undefined
[7] Wake Forest School of Medicine,undefined
来源
GeroScience | 2022年 / 44卷
关键词
Physical performance; Cardiac; Diet; Intervention; Aging;
D O I
暂无
中图分类号
学科分类号
摘要
Intermediate endpoints are needed to evaluate the effect of interventions targeting the biology of aging in clinical trials. A working group identified five blood-based biomarkers that may serve such a purpose as an integrated index. We evaluated the responsiveness of the panel to caloric restriction or aerobic exercise in the context of a randomized clinical trial conducted in patients with heart failure with preserved ejection fraction (HFpEF) with obese phenotype who were predominantly female. Obese HFpEF is highly prevalent in women, and is a geriatric syndrome whose disease pathology is driven by non-cardiac factors and shared drivers of aging. We measured serum Interleukin-6, TNF-α-receptor-I, growth differentiating factor-15, cystatin C, and N-terminal pro-b-type natriuretic peptide at baseline and after 20 weeks in older participants with stable obese HFpEF participating in a randomized, controlled, 2 × 2 factorial trial of caloric restriction and/or aerobic exercise. We calculated a composite biomarker index, summing baseline quintile scores for each biomarker, and analyzed the effect of the interventions on the index and individual biomarkers and their associations with changes in physical performance. This post hoc analysis included 88 randomized participants (71 women [81%]). The mean ± SD age was 66.6 ± 5.3 years, and body mass index (BMI) was 39.3 ± 6.3 kg/m2. Using mixed models, mean values of the biomarker index improved over 20 weeks with caloric restriction (− 0.82 ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm$$\end{document} 0.58 points, p = 0.05), but not with exercise (− 0.28 ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm$$\end{document} 0.59 points, p = 0.50\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$0.50$$\end{document}), with no evidence of an interaction effect of CR ×\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\times$$\end{document} EX ×\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\times$$\end{document} time (p = 0.80) with adjustment for age, gender, and BMI. At baseline, the biomarker index was inversely correlated with 6-min walk distance, scores on the short physical performance battery, treadmill test peak workload and exercise time to exhaustion (all ρ\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\rho$$\end{document}s = between − 0.21 and − 0.24). A reduction in the biomarker index was also associated with increased 4-m usual walk speed (ρ\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\rho$$\end{document}s =  − 0.31). Among older patients with chronic obese HFpEF, caloric restriction improved a biomarker index designed to reflect biological aging. Moreover, the index was associated with physical performance and exercise tolerance.
引用
收藏
页码:983 / 995
页数:12
相关论文
共 335 条
  • [1] Barzilai N(2016)Metformin as a tool to target aging Cell Metab 23 1060-1065
  • [2] Crandall JP(2016)Strategies and challenges in clinical trials targeting human aging J Gerontol A Biol Sci Med Sci 71 1424-1434
  • [3] Kritchevsky SB(2018)Development of clinical trials to extend healthy lifespan Cardiovasc Endocrinol Metab 7 80-83
  • [4] Espeland MA(2018)A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup Geroscience 40 419-436
  • [5] Newman JC(2016)Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial JAMA 315 36-46
  • [6] Milman S(2017)Evolution of a geriatric syndrome: pathophysiology and treatment of heart failure with preserved ejection fraction J Am Geriatr Soc 65 2431-2440
  • [7] Hashmi SK(2021)Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review J Am Coll Cardiol 78 1166-1187
  • [8] Austad SN(2013)Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction Am J Med 126 393-400
  • [9] Kirkland JL(2001)Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study J Am Coll Cardiol 37 1042-1048
  • [10] Halter JB(2006)Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 251-259